{"input_url":"https://www.nature.com/articles/s41563-025-02453-x","gnews_decode":"https://www.nature.com/articles/s41563-025-02453-x","http_status":200,"final_url":"https://www.nature.com/articles/s41563-025-02453-x","html_length":214533,"trafilatura_result":"ok","text_length":1862,"text_preview":"Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are a promising platform to treat cardiac pathologies, namely infarcted tissue. Current methods for the transplantation of hiPSC-CMs into the heart often result in differentiated cells that do not fully mimic the phenotype, prope","verdict":"OK"}